Research News - October 15, 2021

 

         
 
October 15, 2021
ANNOUNCEMENTS
 

1. 2021 MGRI Image Awards: People's Choice Voting is Open!
2. 2022 Innovation Discovery Grant (IDG) Open!
3. This week is the Mass General Brigham Information Privacy and Security Fall Awareness Week 2021!
4. Flu vaccination exemption requests due October 15

EVENTS
 

1. QI Bootcamp for Clinical Researchers and Study Staff
2. Learn about the Analytics Enclave at the ERIS Open House
3. Harvard Catalyst: 5 Senses Seminar
4. Resources for Conducting Global Health Research at MGH
5. Human Subjects Research Recordkeeping and Record Retention
6. Virtual Trivia Night
7. ClinicalTrials.gov Registration and Results Reporting
8. The Chester Pierce Research Society
9. IDEA Symposium: Digital Health in Massachusetts
10. Virtual Research Technical Talk
11. MGH Immunology Virtual Seminar Series
12. A Clinical Research Fellow’s Guide to Mentoring and Resources
13. 2021 NIH Virtual Seminar on Program Funding and Grants Administration
14. 2021 Virtual Tumor Course
15. Qualitative and Mixed Methods Capacity Building Workshop for Research Teams

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. MGH Research Scholars 2022
3. The MGH Claflin Distinguished Scholar Awards
4. Howard M. Goodman Fellowship 2022
5. Damon Runyon Clinical Investigator Award
6. HMS Foundation Funds Fall 2021 Cycle
7. Pilot Grants: Up to 50K for Proposals on the Five Senses: Input & Response
8. Familial RUNX1 Grant Program: RUNX1 Early Career Investigator Grant Program, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)
9. Innovation Grant, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)
10. NIH Research Supplements to Promote Diversity in Health-Related Research
11. Job Research Foundation Announces 4th Round of Funding
12. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
13. Limited Submission Funding Opportunities
14. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. 2021 MGRI Image Awards: People's Choice Voting is Open!

This year we received a record number of images, and we can't wait to share them with you! Be sure to check out the Mass General Research Institute Facebook page starting Monday, October 11, to view all the images from this year's Awards and vote on your favorites! 

Voting will be closely monitored by MGRI staff until October 22nd for the People's Choice category. To review Awards rules, please visit Bench Press. Play fair and have fun!

 
2. 2022 Innovation Discovery Grant (IDG) Open!

Applications will be accepted through October 26, 2021. Submission is via the IDG website.

IDG funding opportunity is open to all clinical and technology types. Individual awards up to $100,000 will be made (inclusive of 15% IDC). IDG stimulates new inventive concepts, identifies areas significant translational potential, and accelerates commercial outcomes. All Mass General Brigham faculty and employees are encouraged to apply. 

To learn more and see a list of past awardees and projects, please visit Innovation Discovery Grants.

  • $3.6 Million has been awarded to 59 projects.
  • $196 Million has been received to further the development of the IDG-supported technologies, a 54-fold increase on the funds awarded
  • 14 New Companies are based on IDG-supported technologies
  • 19 Licenses Agreements have been executed to further their development

Thank you for advancing innovation throughout Mass General Brigham.

 
3. This week is the Mass General Brigham Information Privacy and Security Fall Awareness Week 2021!

From the ransomware pipeline attack to the SolarWinds breach, last year has been hectic in the cybersecurity space. Now, it’s more important than ever to recognize October as Cybersecurity Awareness month, and this week as Fall Information Security & Privacy Awareness Week.

Learn how to Keep it Safe & Secure with tips and best practices to protect yourself and others. Explore our digital event page on The Pulse — play games, take our poll and much more. Every time you participate, you get an entry into our Amazon gift card raffle. Do your part, be cybersmart!
We APPRECIATE and THANK YOU ALL for your efforts especially during these unprecedented times for all you do to keeping our patient, workforce and community Safe & Secure.

Questions? Please contact the Massachusetts General Hospital Privacy Office
Intranet: https://apollo.massgeneral.org/hipaa/   
Phone: 617-726-1098
Email: MGHPOPP@Partners.org

 
4. Flu vaccination exemption requests due October 15

To protect the safety of all patients and staff, Mass General Brigham requires that all employees receive a flu vaccine by November 12, 2021, unless they are approved for a medical or religious exemption.

It is critical that you protect yourself so that you and those around you, including co-workers, patients, family members and friends, stay healthy this winter. It is more important than ever to be vaccinated for the flu during the COVID-19 pandemic because it will reduce the prevalence of flu-like symptoms and the need for COVID-19 testing. Flu shots also decrease the pressure on our already stressed health care system from visits and hospitalizations due to the flu.

Learn more about how to apply for a flu vaccination exemption request, how to submit proof of vaccination and much more.

View the list ofscheduled system-wide flu clinics.

 
Back to top
EVENTS
 
1. QI Bootcamp for Clinical Researchers and Study Staff

Monday, October 18, 2021, 10:00 AM -12:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Human Research Affairs Compliance and Education Office
The QI Program Clinical Research Bootcamp is a “clinical research 101” for study staff and investigators. The course is not only an introduction to clinical research for new investigators and study staff but also good review for experienced study teams.  Many teams include this course as part of the onboarding process for new study staff.  The course covers research regulations, GCP guidelines, and institutional policies relevant to the day to day conduct of clinical research.  Topics include:

  • Informed Consent documentation
  • Study Documentation (subject files, source documents, and data collection forms)
  • Unanticipated Problems, Deviations and Violations
  • Investigational Product Management and Accountability
  • Regulatory Binder and Essential Documents
  • ClinicalTrials.Gov
  • Inspections and audits 
  • Other relevant topics

*This course is worth 2 RCR Credits.

Register here.

Click here to learn more about the QI Bootcamp for Clinical Researchers and Study Staff.  Please contact  Tiereny Morrison-Rohlfs with any questions.

 
2. Learn about the Analytics Enclave at the ERIS Open House

Monday, October 18, 2021, 1:00 – 3:00 PM, Zoom

Short presentations will highlight applications, platforms and IT services available for collecting, managing and analyzing data for research and innovation. Throughout the event there will be opportunities for virtual networking and Q&A with subject matter experts and support teams. The Analytics Enclave, "Enclave Platform", is a highly secure, privacy-aware, data ecosystem equipped with self-service AI, machine learning, and research data tools that facilitate on-demand data analysis at the project-, program-, or institution-level.

Register online and contact rcc@partners.org with any questions or concerns.

 
3. Harvard Catalyst:  5 Senses Seminar

Tuesday, October 19, 2021, 11:30 AM – 1:00 PM, Zoom

Please join us to learn more about our new pilot grant opportunity on senses and perception and hear the exciting work of four Harvard University investigators at the forefront of research about the senses as they relate to human health.  Registration is required.

Agenda:

Introduction
Eva C. Guinan, MD, Professor of Radiation Oncology, Dana-Farber Cancer Institute
Program Director, Translational Innovator, Harvard Catalyst

Layout Parser: A Unified Toolkit for Deep Learning Based Image Analysis
Melissa Dell, PhD, Professor of Economics, Harvard University

Function, Dysfunction, and Restoration of Auditory Transduction
Jeffrey Holt, PhD, Professor of Otolaryngology Head and Neck Surgery, Boston Children's Hospital and Harvard Medical School

The Sense of Smell in the Age of COVID
David Brann, BA, PhD Student in Neuroscience, Harvard Medical School

Harnessing Sensory Processing for Improving Speech in Neurological Voice Disorders
Kristina Simonyan, MD, PhD, Associate Professor of Otolaryngology Head and Neck Surgery
Mass Eye and Ear

Click here to register by Monday, October 18, 2021.

 
4. Resources for Conducting Global Health Research at MGH

Wednesday, October 20, 2021, 12:00 – 1:00 PM, Zoom

Jessica Haberer, Jodi Ansell, and Kate Bell will provide an overview of the scientific and administrative resources available at the MGH Center for Global Health to support research with international partners.

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
5. Human Subjects Research Recordkeeping and Record Retention

Wednesday, October 20, 2021, 1:00 – 2:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Human Research Affairs Compliance and Education Office
Investigators are required to maintain records of their human research activities. Good recordkeeping is essential for verifying the integrity of study data produced and for demonstrating investigator compliance with applicable regulations, and institutional policies and procedures.  This presentation will cover: recordkeeping requirements for regulatory and subject files, maintenance and storage options, common errors identified in inspections and audits, as well as retention requirements for study files.  

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
6. Virtual Trivia Night

Thursday, October 21, 2021, 7:00 – 8:30 PM, Zoom

Back by popular demand, the CNY Vitality and Advocacy Committee is excited to host another FREE MGH Virtual Trivia Night on Thursday, October 21st.

All researchers, trainees, and staff are welcome to join!

Please organize your team (no more than 8 people/team) and register using the link below.  ALL players must register. When you register, you can provide a Team Name if you have a group of teammates in mind. If not, just enter “Free Agent” to be assigned to a team the day of the event!

We expect a large turn out, so register your team now to reserve a spot.  The number of teams will be capped at 60 total!

A link to the Zoom event will be provided upon registration.  Please ensure you log on 10-20 minutes prior to the event.

Click here to register.

 
7. ClinicalTrials.gov Registration and Results Reporting

Friday, October 22, 2021, 10:00 – 11:30 AM, Zoom

Speaker: Pamela Richtmyer, Director, Human Research Affairs Compliance and Education Office
This course will provide participants with information on the requirements for clinical trials registration on ClinicalTrials.gov, results reporting, record maintenance, and consequences for noncompliance.  The course is recommended for investigators and study staff involved in the conduct of clinical trials registration and results reporting or those interested in registering research studies to meet ICMJE publication requirements.   *This course is worth 1 RCR credit.

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
8. The Chester Pierce Research Society

Friday, October 22, 2021, 12:00 – 1:00 PM, Zoom

The Chester Pierce Research Society (CPRS) is sponsored by the Center for Diversity and Inclusion (CDI).  CPRS is a speaker series named in honor of MGH's late Professor Emeritus in Psychiatry, Chester Pierce. Dr. Pierce was the first and most senior African-American physician-scientist at MGH. CPRS is designed to promote diversity and health equity by featuring the novel research of investigators to the MGH community.

Obesity in Pediatrics: Our Understanding and Consideration of Pharmacologic and Surgical Treatment Approaches

Fatima Cody Stanford, MD, MPH, MPA
Obesity Medicine Physician for Adults, Adolescents, and Children at the MGH Weight Center
Director of Equity, MGH Medicine, Endocrine Division
Director of Diversity, Nutrition Obesity Research Center at Harvard
Core Faculty, MGH Mongan Institute of Health Policy 
Assistant Professor-Medicine & Pediatrics, Harvard Medical

Click here to RSVP and for more details

 
9. IDEA Symposium:  Digital Health in Massachusetts

Wednesday, October 27, 2021, 1:00 PM, Zoom

Join industry experts Laurance Stuntz, Director, Massachusetts eHealth Institute, MassTech (MeHI), Katie Green, Program Manager, Digital Health Sandbox, Massachusetts eHealth Institute, MassTech (MeHI), Julian Goldman, MD, Medical Director MGB Biomedical Engineering, MGB; Director, Medical Device Plug-and-Play Interoperability Program (MD PnP), MGH, and Caroline Coy, MPH, Manager, Strategy Implementation, BWH, present on partner organizations, resources and funding from public resources and engagement opportunities.

Click here to register.

Missed earlier IDEA Symposiums?  Click here to re-watch them at your leisure!

About IDEA Symposium 
Mass General Brigham Innovation Digital Education Academy (IDEA) is a new, year-long program focused on innovation and digital health. Designed for faculty, staff and innovators within our System, each month we will host a special session highlighting key individuals and innovations happening within the Mass General Brigham digital health space. Through this program, you will have the opportunity to: 

  • Stay up-to-date and informed on innovations within the Mass General Brigham digital health space. 
  • Explore, learn, and understand the potential of innovative digital health solutions to transform research, care, patient experience, and operations.  
  • Learn the necessary skills, technologies, organizational enablers, and constraints for successfully identifying, verifying, and adopting new digital health solutions.  

Learn more about this year-long program and register for future sessions at the IDEA webpage. We look forward to your participation.

 
10. Virtual Research Technical Talk

Thursday, October 28, 2021, 12:00 – 2:00 PM, Teams

This month will feature a presentation of how one Massachusetts Eye and Ear lab uses computational and statistical genomics approaches to identify variants, genes and pathways associated with complex diseases.  The second presentation discusses the European Union (US) General Data Protection (GDPR) and data security at Mass General Brigham. This monthly meeting is hosted by Enterprise Research IS and geared for research IT administrators and managers who support research and innovation departments but is open to anyone in the Mass General Brigham community. 

Subscribe to receive the monthly meeting invite if you’re interested in learning more or attending.

Click here to learn more about the Virtual Research Technical Talk

 
11. MGH Immunology Virtual Seminar Series

Thursday, October 28, 2021, 12:00 PM, Zoom

Neuroimmune Regulation of Itch
Brian S. Kim, M.D., M.T.R., F.A.A.D. Washington University School of Medicine

Click here to join via Zoom.

To learn more about the MGH Immunology Seminar Series, please click here.

 
12. A Clinical Research Fellow’s Guide to Mentoring and Resources

Friday, October 29, 2021, 11:00 AM – 12:30 PM, Zoom

This orientation program will provide a networking opportunity for new clinical research fellows. Dr. Karen Miller will discuss strategies and resources for a successful research fellowship and career at MGH. Dr. Andrew Nierenberg will introduce the Division of Clinical Research (DCR) and describe resources available to support new fellows conducting clinical research.

Course outline:
11:00-11:10 Welcome and Introduction
11:10-11:35 Keys to a successful research career at MGH, including available resources
11:35-12:00 Division of Clinical Research Resources
12:00-12:30: Fellows Q&A

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
13. 2021 NIH Virtual Seminar on Program Funding and Grants Administration

Monday, November 1, 2021 – Thursday, November 4, 2021

The NIH Regional Seminars, which NIH has held once or twice a year for decades, have been great opportunities to help researchers, research administrators, trainees and others to better understand the NIH grants process. We encourage you to join us as we go virtual once again, even if you participated last year. This free, four-day virtual event covers a broad range of grant policy, program, and process topics from application through award closeout.  Click here for more info.

To view the full four-day program, click here.

 
14. 2021 Virtual Tumor Course

Monday, November 2, 2021 – Thursday, November 4, 2021

36TH Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology

For comprehensive information about this course, including faculty, schedule, and pricing,
please visit the 36th Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology website
The “36th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology, metabolism and chronobiology. This will include chimeric antigen receptor (CAR) T-cell therapies and the role of microbiome as newly introduced topics this year. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.

The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.  

Harvard Medical School’s secure online registration

Click here to for an overview 

Click here to view the brochure

 
15. Qualitative and Mixed Methods Capacity Building Workshop for Research Teams

Friday, November 5, 2021, 10:00 AM – 3:00 PM, Zoom

*Application Required

Application Deadline Friday, October 15 at 11:59 PM

Speakers: Elyse Park, PhD, Lara Traeger, PhD, Christina Psaros, PhD, Vanessa Merker, PhD
Sponsored by the MGH Division of Clinical Research and the Mongan Institute of Health Policy
This course is intended for research teams who are planning or conducting a qualitative and mixed methods research project.  Workshop participants will learn to plan and conduct qualitative and mixed methods research as a critical skill set for amplifying stakeholder perspectives in all phases of health research and for reducing current and future health equity challenges. The agenda includes both high-level topics and operational/procedural topics primarily for the qualitative portion of the research. We encourage applications from teams which include 1) collaborators outside of MGH, 2) collaborators who are under-represented in medicine and related fields (including but not limited to psychology, nursing, epidemiology, allied health), and 3) project topics that are focused on health in underserved populations.

Apply here.

Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.
 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

  • No upcoming deadlines

Recently added:

 
2. MGH Research Scholars 2022

Applications are now being accepted by the Mass General Research Institute (MGRI) for the MGH Research Scholars program

What is it?
The MGH Research Scholars program was established with the aim of supporting MGH research faculty who are pursuing research at the level of Assistant and Associate Professor.  The intent of these awards is to support the careers of outstanding MGH investigators doing cutting-edge research that is highly innovative and expected to result in fundamental scientific discoveries and/or clinical applications.  MGH Research Scholar grants are awarded by the Mass General Research Institute (MGRI). Applicants will be asked to choose one of three categories based on their area of research: clinical research, fundamental research, or population and healthcare research.

How much is each award?
These awards are for $500,000 over 5 years; and will be funded at $100,000 per year, including 15% indirect costs.

When is the deadline?
Tuesday, November 2, 2021 – 5:00 PM

How do I learn more and apply?

 
3. The MGH Claflin Distinguished Scholar Awards

Applications are now being accepted by the Executive Committee on Research (ECOR) for the Claflin Distinguished Scholar Awards!

What are the Claflin Awards?
Although women scientists are recruited to Massachusetts General Hospital (MGH) programs, their advancement to senior faculty positions is still far less frequent than that of their male counterparts.  In 1993, The Women in Academic Medicine Committee, originally chaired by Mrs. Jane D. Claflin, Honorary Trustee, was established to facilitate the academic careers of women in science at MGH.  Recognizing that a significant obstacle to career advancement is the difficulty of maintaining research productivity during the child-rearing years, this Committee, with the sponsorship of the Executive Committee on Research (ECOR), established the Claflin Distinguished Scholar Awards.  It is intended that this funding will increase opportunities for women to advance to senior positions in academic medicine.

How much is each award?
These are two year awards for $50,000 per year in direct costs, plus 15% for indirect costs.

When is the deadline?
Tuesday, November 9, 2021 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online.

 
4. Howard M. Goodman Fellowship 2022

Applications are now being accepted by the Executive Committee on Research (ECOR) for the MGH Howard M. Goodman Fellowship

What is it?
This is an endowed fellowship established by the MGH Department of Molecular Biology in honor of the founding Chief of the Department, Dr. Howard M. Goodman. The award is intended to further the careers of outstanding independent young scientists, who would normally hold the position of Assistant Professor, and have demonstrated the potential to rise to a leadership position in their chosen field. Applicants who hold a full-time appointment in any MGH department and are primarily engaged in research are eligible to apply.

How much is the award?
The award is $100,000 per year for two years plus 15% indirect costs and is effective April 1, 2022.  

When is the deadline?
Tuesday, October 19, 2021 – 5:00 PM

How do I learn more and apply?

Click here to visit the FAQ page.
 
5. Damon Runyon Clinical Investigator Award

A program of the Damon Runyon Cancer Research Foundation

Letters of intent are now being accepted by the Executive Committee on Research (ECOR) for the Damon Runyon Clinical Investigator Award

What are they?
The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

MGH is eligible to nominate a maximum of five (5) candidates.

Who should apply?
Independent assistant professors who hold an MD or MD/PhD. Applicants must be within the first five years of their initial full faculty appointment (cut-off date: July 1, 2017). Candidates holding or awarded R01s (or R01-equivalent grants such as the DP2 and DP5) at the time of application are not eligible to apply.

How much is each award?
$600,000 for a period of three years. Funding in the amount of $200,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator.

This funding opportunity is not exempt from the 15% indirect cost (IDC) floor minimum. However, ECOR policy states that for MGH investigators selected through a competitive process as the institutional nominee in which the grant will bring in less than 15% indirect cost (IDC), ECOR will cover the IDC gap up to a maximum of $50,000 per year.

The applicant must commit to spending 80% of their time conducting research. 

When is the deadline?  
MGH letter of intent deadline: Wednesday, November 10, 2021 at 5:00pm
Sponsor deadline: Tuesday, February 1, 2021 at 4:00pm

How do I learn more about the opportunity?
To see the ECOR letter of intent instructions – Click here
Damon Runyon Clinical Investigator Award– Click here

 
6. HMS Foundation Funds Fall 2021 Cycle

Each year several foundations invite HMS faculty and postdocs to apply for their fellowships and grants, which serve as critical funding at the early stages of a research career.  Interested investigators must first apply for the HMS nomination through the HMS Foundation Funds office, and a committee will select the final candidates to submit applications to the sponsors. 

Awards include:

  • Brain Research Foundation Fay/Frank Seed Grant Program
  • Macy Foundation Faculty Scholars Program
  • Mary Kay Innovative/Translational Cancer Research Award
  • Packard Foundation Fellowship in Science and Engineering

Faculty and postdocs interested in applying for any of the awards listed above can apply for the HMS nomination by submitting an application online no later than Monday, November 8, 2021. For information on application guidelines, click here.
For some awards, MGH receives invitations to submit their own nominations. In this case, MGH faculty must first apply for the MGH nomination through ECOR and a committee at MGH will select the final MGH candidate(s) to submit applications to the foundations. Click here to view a chart of the current opportunities and the Institution that MGH faculty should apply through. Internal announcements are forthcoming for the following opportunities in which MGH is invited to submit their own application:

  • Damon Runyon Clinical Investigator Award
  • Smith Family Foundation: Odyssey Award

Please direct all inquiries regarding the application process at HMS to Clare Lamont, Program Coordinator, Office for Academic and Clinical Affairs, 617-432-7463, clare_lamont@hms.harvard.edu.  If you have questions regarding the MGH application process, please email MGH ECOR, ecor@mgh.harvard.edu

 
7. Pilot Grants: Up to 50K for Proposals on the Five Senses: Input & Response

This funding opportunity will support investigations on any aspect of human sensory systems, or systems-enabling sensory perception, in human health or disease. Proposals on both traditional sensory systems – sight, sound, smell, taste and touch – which gather, organize, and integrate external stimuli, as well as on internal sensory systems (vestibular, spatial orientation, pain, and others) are both welcome.

Proposals can address, but are not limited to: sense functionality, injury, disease states, treatment, mitigation, social and societal impacts, and/or public policy.

Examples include human health-related issues such as, but not limited to, the following:

  • Physiology or mechanistic aspects of sensory reception or perception;
  • Innate or acquired impairments of any sensory reception or perception system:
    • age-related changes
    • inborn or acquired physical impediments
    • illness or treatment-related effects  
  • New therapeutics, e.g., drugs, mechanical aids, gene and cell-based therapies, etc.;
  • Impacts on individuals/families/society, e.g., social isolation, depression, ostracization, mental health issues, etc.;
  • Legal/public policy aspects, e.g., ADA, accessibility of public buildings, etc.

As deficits in sensory reception or perception may affect several systems simultaneously, such as vision and hearing, proposals describing the formation of interdisciplinary teams to address multi-sensory integration projects would also be welcome.

This RFA is intended to offer applicants opportunities to conduct important translational research across a wide range of topics.

Proposals addressing healthcare disparities and health equity or focus on or actively recruit underserved, understudied, or special populations, and impacts across the lifespan are encouraged.

Areas of inquiry should focus on translational research and human health. Proposals requiring the use of non-human samples/models will only be considered if there is a clear and direct link to subsequent investigation of some aspect of human health. Proposals investigating basic research questions or those solely limited to pre-clinical applications will not be considered.

Investigators from any field are encouraged to apply. Applications are due November 10, 2021.

Please email reactor@catalyst.harvard.edu to learn more or if you have any questions.

Click here to learn more and to apply.
 
8. Familial RUNX1 Grant Program: RUNX1 Early Career Investigator Grant Program, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)

To promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.

Aims of research proposals must be relevant to the ultimate goal of preventing hematologic malignant transformation in RUNX1-FPD. Proposals that seek to translate from bench to bedside will receive priority.

Example areas of research interests include:

  • Hematopoietic stem cell gene correction strategies that optimize gene editing efficiency, precision and limit off-target effects.
  • Determining the drivers of clonal hematopoiesis and progression to overt malignancy.
  • Identifying strategies to lower the risk of hematologic malignancy in RUNX1-FPD.
  • Understanding the cellular and molecular mechanisms that underlie the inflammatory manifestations of RUNX1-FPD such as eczema, reactive airway disease and GERD.
  • Defining the role of inflammation in leukemic progression in RUNX1-FPD.
  • Determining whether impaired RUNX1-regulated DNA damage response contributes to acquisition of somatic mutations and clonal evolution.

Eligibility requirements (partial list):

  • Applicants must have an MD, PhD or dual MD, PhD (DO, MBBS or equivalent) and be within 5 years of their first faculty appointment as an Assistant Professor or equivalent.
  • Applicants may have research grants from other funding sources during the award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap.
  • Applicants must have research experience working in and a deep understanding of normal or malignant hematopoiesis and/or immunology.
  • One resubmission of a previously unfunded application is allowed. 

Citizenship: Unrestricted
Award Amount: $180,000 paid over 3 years
Indirect Costs: None
Research Management Deadline: December 8, 2021
Application Deadline: December 20, 2021

Click here to visit the website and to learn more.  

 
9. Innovation Grant, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)

The Innovation Grant is designed to provide critical and significant seed funding for researchers with a novel approach to pediatric oncology scientific investigation. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.

Eligibility requirements (partial list):

  • Applicants must have an MD, PhD, or MD/PhD or equivalent and be appointed as faculty (or equivalent) at an academic institution.
  • Applicants must have a track record of publication and funding productivity that demonstrates that the project can be accomplished by the investigators.

Citizenship: Unrestricted
Award Amount: $250,000 paid over 2 years
Indirect Costs: None
LOI Deadline: November 15, 2021
Research Management Deadline: March 23, 2022
(Invited) Proposal Deadline: April 4, 2022

Click here to visit the website and to learn more.

 
10. NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.
 
11. Job Research Foundation Announces 4th Round of Funding

$400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at https://www.jobresearchfoundation.org/grant-proposal-application . Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

 
12.  T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592

The primary mission of this program is to promote the development of a diverse, translational research workforce that is capable of participating and/or leading cross-disciplinary team science relevant for the treatment and prevention of Alzheimer’s disease and AD-related dementias.  The trainee will pursue a targeted research project under the mentorship of world-class researchers in the Harvard research community in three key areas:

  1. biology of aging and neurodegeneration;
  2. data sciences, computational biology, statistics, math/engineering/physics;
  3. drug discovery and development

Most T32 faculty are within the MGH Martinos Center for Biomedical Imaging and/or Massachusetts Alzheimer’s Disease Research Center.  Training includes targeted coursework, didactic lectures, and a dedicated T32 lecture series. General training includes research conduct, diversity and inclusion, mentoring, career development, and grant development activities.

Eligibility: PhD, MD, MD/PhD and U.S. citizen or permanent resident (see NIH PAR-18-524), with rolling admission for 4 training slots.  Our goal is to recruit a truly diverse T32 trainee pool that is highly representative of URM and women trainees.

Additional information: Please see  https://pricelab.martinos.org/t32-adrd/ for further information including application instructionsPlease submit questions to:  Krystal Whitfield (T32 Administrative Contact) at T32ADRD@mgh.harvard.edu

 
13. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                        
Please click here for more information and for our internal deadlines.

  • Neurosurgeon Research Career Development Program (NRCDP) (K12 Independent Clinical Trial Not Allowed) – NEW!
  • Responsive Grants, Retirement Research Foundation (RRF)
  • NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional)
  • Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) 
  • Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)  
  • Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed) – NEW!
  • SUNBEAM – Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
14. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 10/15/21

  • William and Sandra Bennett Clinical Scholars Program, ASN Foundation/American Society of Nephrology. $100,000. Application Deadline: December 8
  • Entelligence Young Investigator Program, Actelion Pharmaceutical US, Inc. $100,000. LOI Deadline: November 1
  • AACR Career Development Award to Further Diversity, Equity, and Inclusion in Cancer Research, American Association for Cancer Research (AACR) NEW! $300,000. Application Deadline: November 30
  • AACR Career Development Award to Further Diversity, Equity, and Inclusion in Clinical Cancer Research, American Association for Cancer Research (AACR) NEW! $375,000. Application Deadline: November 30
  • Pinnacle Research Award in Liver Disease, American Association for the Study of Liver Diseases (AASLD). $300,000. Application Deadline: December 2
  • ACG/ASGE Epidemiologic Research Award in Gastrointestinal Endoscopy, American Society for Gastrointestinal Endoscopy (ASGE). $50,000. Application Deadline: December 3
  • ASGE Diversity and Inclusion Research Award, American Society for Gastrointestinal Endoscopy (ASGE) NEW! $50,000. Application Deadline: December 10
  • ASGE Research Award, American Society for Gastrointestinal Endoscopy (ASGE). $75,000. Application Deadline: December 10
  • ASRM Large Grant, American Society for Reproductive Medicine (ASRM) NEW! $750,000. LOI Deadline: November 1
  • AST TIRN Fellowship Research Grants, American Society of Transplantation (AST). $100,000. Application Deadline: December 1
  • AST TIRN Fellowship Research Grants - Patient-Oriented Fellowship Grants, American Society of Transplantation (AST) NEW! $75,000. Application Deadline: December 1
  • Novice Research Awards, Gerber Foundation. $20,000. Concept Paper Deadline: November 15
  • Pediatric Research Grants, Gerber Foundation. $350,000. Concept Paper Deadline: November 15
  • Blood Cancer Discoveries Grant Program, Leukemia & Lymphoma Society (LLS) NEW! $750,000. LOI Deadline: October 28
  • Career Development Program: Multiple Categories, Leukemia & Lymphoma Society (LLS). $600,000. Eligibility Phase Deadline: November 1 & Abstract Deadline: November 15
  • Influential Medicine Providing Access to Clinical Trials (IMPACT), Leukemia & Lymphoma Society (LLS). $1.25 million. LOI Deadline: December 15
  • Specialized Center of Research Program, Leukemia & Lymphoma Society (LLS). $5 million. LOI Deadline: December 1
  • Translational Research Program (TRP), Leukemia & Lymphoma Society (LLS). $600,000. LOI Deadline: October 29
  • McKnight Scholar Awards, McKnight Foundation/McKnight Endowment Fund for Neuroscience. $225,000. Application Deadline: January 10
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

Two Meditation Sessions are Offered Each Week!

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending October 15, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu